{
  "id": [
    "26597956"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "26597956"
  ],
  "pmcid": [
    "PMC4733138"
  ],
  "doi": [
    "10.1007/s11096-015-0219-8"
  ],
  "title": [
    "The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour."
  ],
  "authorString": [
    "de Boer SA, Lefrandt JD, Petersen JF, Boersma HH, Mulder DJ, Hoogenberg K."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "de Boer SA"
          ],
          "firstName": [
            "Stefanie Amarens"
          ],
          "lastName": [
            "de Boer"
          ],
          "initials": [
            "SA"
          ],
          "affiliation": [
            "Department of Vascular Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands."
          ]
        },
        {
          "fullName": [
            "Lefrandt JD"
          ],
          "firstName": [
            "Joop Daniel"
          ],
          "lastName": [
            "Lefrandt"
          ],
          "initials": [
            "JD"
          ],
          "affiliation": [
            "Department of Vascular Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands."
          ]
        },
        {
          "fullName": [
            "Petersen JF"
          ],
          "firstName": [
            "Japke Frida"
          ],
          "lastName": [
            "Petersen"
          ],
          "initials": [
            "JF"
          ],
          "affiliation": [
            "Department of Vascular Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands."
          ]
        },
        {
          "fullName": [
            "Boersma HH"
          ],
          "firstName": [
            "Hendrikus Hessel"
          ],
          "lastName": [
            "Boersma"
          ],
          "initials": [
            "HH"
          ],
          "affiliation": [
            "Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands."
          ]
        },
        {
          "fullName": [
            "Mulder DJ"
          ],
          "firstName": [
            "Douwe Johannes"
          ],
          "lastName": [
            "Mulder"
          ],
          "initials": [
            "DJ"
          ],
          "affiliation": [
            "Department of Vascular Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands."
          ]
        },
        {
          "fullName": [
            "Hoogenberg K"
          ],
          "firstName": [
            "Klaas"
          ],
          "lastName": [
            "Hoogenberg"
          ],
          "initials": [
            "K"
          ],
          "affiliation": [
            "Department of Internal Medicine, Martini Hospital, Groningen, The Netherlands. HoogenK@mzh.nl."
          ]
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "1"
      ],
      "volume": [
        "38"
      ],
      "journalIssueId": [
        "2368416"
      ],
      "dateOfPublication": [
        "2016 Feb"
      ],
      "monthOfPublication": [
        "2"
      ],
      "yearOfPublication": [
        "2016"
      ],
      "printPublicationDate": [
        "2016-02-01"
      ],
      "journal": [
        {
          "title": [
            "International journal of clinical pharmacy"
          ],
          "ISOAbbreviation": [
            "Int J Clin Pharm"
          ],
          "medlineAbbreviation": [
            "Int J Clin Pharm"
          ],
          "NLMid": [
            "101554912"
          ],
          "ISSN": [
            "2210-7703"
          ],
          "ESSN": [
            "2210-7711"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2016"
  ],
  "pageInfo": [
    "144-151"
  ],
  "abstractText": [
    "Glucagon-like peptide-1 receptor agonists (GLP-1 RA) added to insulin in type 2 diabetes patients have shown to lower body weight, improve glycaemic control and reduce total daily insulin dose in short term studies, although the individual response greatly varies.To evaluate GLP-1 RA treatment on body weight, glycaemic control and total daily insulin dose in obese, insulin-using type 2 diabetes patients after 2 years follow-up in a real life setting and to explore a possible relation with eating behaviour.The Martini Hospital and the University Medical Center in Groningen in the Netherlands.Eligible patients were at least 18 years of age, were on insulin therapy and obese (BMI > 30 kg/m(2)), started GLP-1 RA treatment. At baseline eating behaviour was classified according to the validated Dutch Eating Behaviour Questionnaire. A 2 years follow-up was performed. Main outcome measures Body weight, HbA1c and total daily insulin dose.151 Patients started with exenatide or liraglutide. 120 patients completed the 2 years follow-up. From baseline to 2 years, body weight (mean ± SD) changed from 117.9 ± 22.1 to 107.9 ± 22.9 kg (P < 0.0001), HbA1c (median, IQR) changed from 7.9 (7.2-8.9) to 7.6 (6.9-8.3) % [63 (55-74) to 60 (52-67) mmol/mol] (P < 0.0001), total daily insulin dose changed from 90 (56-150) to 60 (0-100) Units/day (P < 0.0001). Weight change differed between eating behaviour groups (P < 0.001) in which external eating behaviour (n = 17) resulted in the smallest decline (-3.1 %) and restrained (n = 41) in the greatest (-10.3 %) in comparison with emotional (n = 37, -8.5 %) and indifferent (n = 25, -9.6 %) eating behaviours.Two year of GLP-1 RA treatment resulted in a sustained reduction of weight, HbA1c and total daily insulin dose in obese, insulin-using type 2 diabetes patients in a real life setting. Largest weight loss was achieved in patients with a predominant restraint eating pattern while a predominant external eating pattern resulted in the smallest weight reduction."
  ],
  "affiliation": [
    "Department of Vascular Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print-Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "research-article",
        "Multicenter Study",
        "Journal Article",
        "Observational Study"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Venoms"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "AE"
                  ],
                  "qualifierName": [
                    "adverse effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Diabetes Mellitus, Type 2"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "BL"
                  ],
                  "qualifierName": [
                    "blood"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "DI"
                  ],
                  "qualifierName": [
                    "diagnosis"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Obesity"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DI"
                  ],
                  "qualifierName": [
                    "diagnosis"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "PP"
                  ],
                  "qualifierName": [
                    "physiopathology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PX"
                  ],
                  "qualifierName": [
                    "psychology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Weight Loss"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Insulin"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "AE"
                  ],
                  "qualifierName": [
                    "adverse effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Hemoglobin A, Glycosylated"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Blood Glucose"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Peptides"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "AE"
                  ],
                  "qualifierName": [
                    "adverse effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Anti-Obesity Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "AE"
                  ],
                  "qualifierName": [
                    "adverse effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Hypoglycemic Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AE"
                  ],
                  "qualifierName": [
                    "adverse effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Body Mass Index"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Treatment Outcome"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Drug Therapy, Combination"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Prospective Studies"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Feeding Behavior"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Time Factors"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Aged"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Middle Aged"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Netherlands"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Female"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Male"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Incretins"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "AE"
                  ],
                  "qualifierName": [
                    "adverse effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Biomarkers"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "BL"
                  ],
                  "qualifierName": [
                    "blood"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Surveys and Questionnaires"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Glucagon-Like Peptide-1 Receptor"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "AG"
                  ],
                  "qualifierName": [
                    "agonists"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Liraglutide"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "AE"
                  ],
                  "qualifierName": [
                    "adverse effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Diabetes mellitus",
        "Weight loss",
        "Insulin Therapy",
        "Eating Behaviour",
        "Glp-1 Receptor Agonist"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Blood Glucose"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Peptides"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Venoms"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Hypoglycemic Agents"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Hemoglobin A, Glycosylated"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Anti-Obesity Agents"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "hemoglobin A1c protein, human"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Incretins"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Insulin"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "glucagon-like peptide-1 receptor"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "liraglutide"
          ],
          "registryNumber": [
            "839I73S42A"
          ]
        },
        {
          "name": [
            "exenatide"
          ],
          "registryNumber": [
            "9P1872D4OL"
          ]
        },
        {
          "name": [
            "Biomarkers"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "GLP1R protein, human"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC4733138?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC4733138"
          ]
        },
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1007/s11096-015-0219-8"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "Y"
  ],
  "citedByCount": [
    "3"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2016-12-13"
  ],
  "dateOfCreation": [
    "2016-01-30"
  ],
  "dateOfRevision": [
    "2017-02-24"
  ],
  "electronicPublicationDate": [
    "2015-11-23"
  ],
  "firstPublicationDate": [
    "2015-11-23"
  ]
}